Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2024)

Historic Other Non Operating Income for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to $1.1 million.

  • Contineum Therapeutics' Other Non Operating Income rose 251276.6% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year increase of 67457.63%. This contributed to the annual value of $1.0 million for FY2024, which is 67514.12% up from last year.
  • Contineum Therapeutics' Other Non Operating Income amounted to $1.1 million in Q4 2024, which was up 251276.6% from -$34000.0 recorded in Q3 2024.
  • Contineum Therapeutics' Other Non Operating Income's 5-year high stood at $1.1 million during Q4 2024, with a 5-year trough of -$77000.0 in Q2 2024.